Clinical Trials Logo

Filter by:
NCT ID: NCT00116389 Terminated - Pancreatic Cancer Clinical Trials

Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the 6-month survival rate and safety of talabostat and gemcitabine in patients with stage IV adenocarcinoma of the pancreas.

NCT ID: NCT00119600 Terminated - Cancer Clinical Trials

A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy

Start date: n/a
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of AMG 114 administered subcutaneously for the treatment of chemotherapy induced anemia in subjects receiving multicycle chemotherapy.

NCT ID: NCT00121420 Terminated - Neoplasm Metastasis Clinical Trials

Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases

Start date: n/a
Phase: Phase 2
Study type: Interventional

The primary purpose of the study is to evaluate if motexafin gadolinium with whole brain radiation therapy followed by a stereotactic radiosurgery boost is a safe and effective treatment.

NCT ID: NCT00122512 Terminated - HIV Infections Clinical Trials

Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV

Start date: n/a
Phase: Phase 2
Study type: Interventional

This Phase 2a study involving Tenofovir Disoproxil Fumarate (TDF) will provide extended safety data for high-risk men. Secondarily, the study will assess the feasibility of conducting the trial and evaluate the preliminary effectiveness of TDF 300 mg as an HIV prevention method when taken once a day.

NCT ID: NCT00133484 Terminated - Clinical trials for Bacillus Anthracis (Anthrax)

UMD rPA Regimen Trial in Adults

Start date: n/a
Phase: Phase 2
Study type: Interventional

Objectives are: To confirm the safety and tolerability of 2-dose regimens of 100 g rPA vaccines (3 products) administered by the intramuscular (IM) route to healthy adults.To describe the immunologic responses to 2-dose regimens of 3 rPA vaccines and to compare the responses to those following administration of Anthrax Vaccine Adsorbed (AVA or BioThraxTM), the currently available vaccine. The primary immunologic outcome is the proportion of volunteers in each group that mounts an antibody response (defined as a 4-fold or greater increase from pre-vaccination to post-vaccination of anti-rPA IgG antibody with a minimal concentration of 10 µg/ml as measured by ELISA). Secondary outcomes are time to peak response and GMC of anti-PA antibody at peak for each group. In addition, the following immunologic assays will be performed: toxin neutralization assay, oral fluid ELISA, antibody avidity, IgG subclasses, and B-cell memory,T-cell memory and effector subpopulations.

NCT ID: NCT00143754 Terminated - Hydration Clinical Trials

Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope

Start date: n/a
Phase: Phase 3
Study type: Interventional

Beneficial effect of chronic hydration with salt supplementation in patients with recurrent unexplained syncope is not established. We sought to determine if chronic oral rehydration with salt supplementation improved the tolerance and hemodynamic responses of patients with unexplained recurrent syncope.

NCT ID: NCT00146029 Terminated - Clinical trials for Metastatic Breast Cancer

Companion Pharmacogenetic Study to UMCC 9900/9901

Start date: n/a
Phase: N/A
Study type: Observational

The purpose is to examine the original breast tumor material to see how much of a metabolizing enzyme (CYP3A4) is present in tumor material. The researchers want to see if this is in any way associated with how the patient responded to docetaxel. They also want to examine the genes in the tumor that are responsible for the production of CYP metabolizing enzymes, to see if they are normal or if they have polymorphisms, or change compared to 'normal' CYP metabolizing enzymes.

NCT ID: NCT00155610 Terminated - Diabetes Mellitus Clinical Trials

The Relationship Between Voiding Dysfunction and Intravesical Sensory Threshold in Diabetes Women

Start date: n/a
Phase: Phase 1/Phase 2
Study type: Observational

The investigators will recruit a cross-sectional group of diabetic women in internist clinics. UDS will be applied for voiding function in each case. Intravesical electrical stimulation will be used to test CPT per 5 Hz, 250 Hz, 2000 Hz for the patients. The differences of intravesical CPT between diabetic women with and without voiding dysfunction will be determined.

NCT ID: NCT00164814 Terminated - Clinical trials for Non-Cardiac Chest Pain

The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients

Start date: n/a
Phase: N/A
Study type: Observational

Noncardiac chest pain (NCCP) is a common clinical problem worldwide. In Hong Kong, it has been estimated that about 20% of patients with chest pain are misdiagnosed to have coronary heart disease. Despite its benign nature, this condition causes anxiety, impairs quality of life and consumes a substantial amount of healthcare resources. While acid reflux and motility disorder in the esophagus are often attributed as the cause of NCCP, visceral hyperalgesia of esophagus is now recognized to play a central role in the pathogenesis of this condition. This research project aims to evaluate the role of visceral hyperalgesia in Chinese patients with NCCP. NCCP patients will be evaluated for the prevalence of gastroesophageal reflux disease and esophageal motility disorder by endoscopy, manometry and pH study. The visceral sensory and pain thresholds of these patients will be compared with asymptomatic controls.

NCT ID: NCT00189579 Terminated - Ovarian Cancer Clinical Trials

Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate whether or not the addition of Herceptin may be of benefit to a standard regimen of carboplatin-paclitaxel.